The First Oral GLP-1 Pill for Weight Loss Is Here. Is It as Good as the Injection?

Quick honest answer Not yet, on average. But for a meaningful number of patients, the new oral GLP-1 pill is the right choice. Foundayo (orforglipron) produces around 12% average weight loss in its pivotal trial, with some patients losing up to 15%. Mounjaro (tirzepatide) injection still leads on magnitude, with around 20% average weight loss […]
Protecting Muscle While Losing Weight on GLP-1: Protein, Training and Body Composition

Quick answer Rapid weight loss, including on GLP-1 medicines, can involve the loss of muscle as well as fat. You can protect muscle by eating sufficient protein, performing regular resistance training, and tracking body composition rather than only the number on the scale. At Endocare, a body composition analysis at each visit guides this process, […]
How to Lose 10 kg in 3 Months: What Actually Works

Losing 10 kg in three months is one of the most common weight loss goals people set. It feels ambitious enough to make a real difference to how you look and feel, but realistic enough that it does not require extreme restriction or unsustainable habits. At a pace of roughly 0.5 to 1 kg per […]
Why Am I Not Losing Weight on Mounjaro?

Many patients begin Mounjaro expecting steady weight loss, so it can feel frustrating when the scale does not change as quickly as expected. If you are asking why am I not losing weight on Mounjaro?, you are not alone, this is one of the most common questions doctors hear during follow-up visits. Response to tirzepatide […]
Is Medical Weight Loss Safe? What Patients Should Know Before Starting

Medical weight loss refers to weight reduction supported by prescription medication under structured medical supervision. It is used when excess weight is affecting health or when lifestyle-only approaches have not produced sustained results. Patients often ask: is medical weight loss safe? The answer depends on how treatment is assessed, prescribed, and monitored. This article explains […]
Can I Take Weight Loss Injections During Ramadan?

Yes. Weight loss injections such as GLP-1 medications including Ozempic, Wegovy, and Mounjaro can generally be used during Ramadan without invalidating the fast. Because these injections do not provide nutrition through the digestive system, they are usually treated as non-nutritive medications taken while fasting. For patients already established on treatment, the appetite-regulating effects of GLP-1 […]
Losing Weight in Ramadan: A Doctor-Backed Guide That Protects Your Energy

Ramadan can be a good time to build healthier habits, but it can also leave you tired and, frustratingly, not lighter. The difference usually comes down to how you eat, drink, move and rest around the fast. This guide brings together practical, doctor-backed steps to help you lose weight during Ramadan while keeping your energy […]
The Importance of Taking GLP-1 Therapy Under Medical Supervision

Weight loss injections like Ozempic and Mounjaro are effective tools in managing obesity and type 2 diabetes, helping with weight loss, appetite control, and blood sugar regulation. However, to ensure their effectiveness and safety, it’s crucial to take them under proper medical supervision. Why medical supervision is essential 1) Correct Dosage: The effectiveness of Ozempic, […]
Ramadan and GLP-1 Therapy

During Ramadan, fasting from dawn to sunset poses some challenges for people on GLP-1 therapy, especially those managing type 2 diabetes or obesity. GLP-1 medications like Ozempic and Mounjaro work by regulating blood sugar, stimulating insulin production, and slowing gastric emptying. While fasting can impact blood sugar levels, proper adjustments to medication and lifestyle can […]
World Obesity Day: The Role of GLP-1 Therapy in Combating Obesity

On World Obesity Day (March 4th), we reflect on the global obesity epidemic, its impact on public health, and the need for effective treatment options. Obesity is a complex condition linked to numerous health problems, including heart disease, diabetes, and even certain cancers. As we continue to battle this global issue, GLP-1 therapy has emerged […]